Pharmaceutical Processing

The buzz around AI in drug discovery often centers on generating new molecular ideas. But as computational chemists know, an in silico design is only valuable if it can be efficiently synthesized in the lab and is manufacturable after that. Merck KGaA, Darmstadt, Germany, with its roots in both chemistry (via Sigma-Aldrich) and life science…

Johnson & Johnson today announced it broke ground on a $2 billion biologics manufacturing facility in Wilson, N.C., a small portion of the company’s $55 billion U.S. investment initiative over the next four years. The 500,000 ft² facility will expand the company’s capacity to develop and produce advanced therapies for oncology, immunology and neurological diseases.…

Currax Pharmaceuticals today announced the FDA approved a second manufacturing site for its Contrave medication. The approval of the second site enhances the production capacity for the company’s oral weight loss medication, also marketed as Mysimba in Europe. Currax said it is investing in manufacturing and advancing clinical research. “At Currax, we are steadfast in…

Emergent BioSolutions announced today that it entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility. The company agreed to sell the plant to Syngene, a leading global CRDMO, for a total value of $36.5 million. The plant includes manufacturing, laboratory, warehousing and office space, plus multiple monoclonal antibody (mAbs) manufacturing lines. Syngene…

CordenPharma announced today that it progressed with its more than €1 billion expansion plan for peptide development and manufacturing. As part of its strategy, the company finalized plans to establish a new, state-of-the-art peptide manufacturing facility in Switzerland. located at Getec Park in Muttenz, the plant sits near Basel, a major European biotech and pharma…

Veranova announced today that it plans to move its corporate headquarters to a Massachusetts manufacturing and development facility. The Devens, Massachusetts, facility is one of the company’s principal sites for manufacturing and development. The FDA-approved facility sits strategically located near the Boston pharmaceutical and biotech hub as well. It also features a center of excellence…

Sherwin-Williams High-Performance Flooring announced the launch of Accelera One, a grout and topcoat technology for pharmaceutical manufacturing environments. The technology offers benefits for pharmaceutical, life sciences, R&D and biopharma manufacturing spaces. A next-generation, ultra-high solids coating formulated to minimize downtime, it can also enhance durability and support green building goals. Accelera One delivers rapid cure…

Eli Lilly (NYSE:LLY) announced today that it plans to boost domestic pharmaceutical production with four new U.S. manufacturing sites. The company’s investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020. Indianopolis-based Eli Lilly says three of the future U.S. sites will focus on manufacturing active pharmaceutical…

Selkirk Pharma announced today that it launched ClinFast, a service designed to assist in the biotech and pharma fill/finish process. The Spokane, Washington-based pharmaceutical manufacturer called the service “paradigm-shifting.” It designed ClinFast to assist clinical-stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies. ClinFast can reduce production timelines while maintaining…

Jabil announced that it acquired Pharmaceutics International, Inc. (Pii), a CDMO specializing in pharmaceutical manufacturing. Pii offers early stage, clinical and commercial volume aseptic filling, lyophilization and oral solid dose manufacturing. Jabil completed the acquisition on Feb. 3. “As the pace of healthcare innovation accelerates, pharmaceutical companies need partners who can help them scale rapidly…